| Identification | Back Directory | [Name]
N-((4-(5-Methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)acetaMide | [CAS]
198471-06-6 | [Synonyms]
Parecoxib-008
PARECOXIB SODIUM G
Parecoxib Sodium-16
Parecoxib Impurity 10
Valdecoxib Impurity 10
Parecoxib Sodium Impurity I
Parecoxib Sodium Impurity X
Parecoxib Sodium Impurity 12
Parecoxib Sodium Impurity 18
Parecoxib Impurity C（Valdecoxib Impurity）
N-((4-(5-Methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)
N-((4-(5-Methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)acet...
N-[[4-(5-Methyl-3-phenyl-4-isoxazolyl)phenyl]sulfonyl]acetamide
N-ACETYL-4-(5-METHYL-3-PHENYL-ISOXAZOL-4-YL)-BENZENESULFONAMIDE
N-((4-(5-Methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)acetaMide
N-[4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)phenyl]sulfonylacetamide
AcetaMide, N-[[4-(5-Methyl-3-phenyl-4-isoxazolyl)phenyl]sulfonyl]-
Parecoxib impurity 9/N-((4-(5-methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)acetamide | [Molecular Formula]
C18H16N2O4S | [MDL Number]
MFCD26940316 | [MOL File]
198471-06-6.mol | [Molecular Weight]
356.4 |
| Chemical Properties | Back Directory | [density ]
1.288±0.06 g/cm3(Predicted) | [storage temp. ]
2-8°C | [pka]
5.10±0.10(Predicted) | [InChI]
InChI=1S/C18H16N2O4S/c1-12-17(18(19-24-12)15-6-4-3-5-7-15)14-8-10-16(11-9-14)25(22,23)20-13(2)21/h3-11H,1-2H3,(H,20,21) | [InChIKey]
UMBILIGVYYXBRD-UHFFFAOYSA-N | [SMILES]
C(NS(C1=CC=C(C2=C(C)ON=C2C2=CC=CC=C2)C=C1)(=O)=O)(=O)C |
| Hazard Information | Back Directory | [Uses]
N-[[4-(5-Methyl-3-phenyl-4-isoxazolyl)phenyl]sulfonyl]acetamide is used in the microbial biotransformations of valdecoxib using microbial cultures to predict mammalian drug metabolism. |
|
|